Advertisement

Gender and Justice in the Gene Age: The Challenges Presented by Reproductive and Genetic Biotechnologies

Abstract

This chapter examines some of the challenges created by the rapid emergence, and in some prosperous nations, unregulated development of new reproductive and genetic biotechnologies and biomedical protocols that use and impact women’s reproductive capacity. It also reports on the ova trade in the United States, and attempts at enforceable regulatory oversight of reproductive biotechnologies and egg donation in the US. Lastly, this article considers the social justice challenges posed by some emerging biomedical technologies in the context of distributive justice issues like women’s bodily integrity and ‘red biotechnologies’, intergenerational justice, existing health equity resource sharing, and the long-standing challenge to the women’s movement to support reproductive justice for marginalized women.

Keywords

Biomedical technologies ova trade reproductive justice women’s bodily integrity women’s movement 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ahuja, K., Simons, E., & Edwards, R. (1999). Money, morals and medical risks: conflicting notions underlying the recruitment of egg donors. Human Reproduction, 14(2), 279–284.PubMedCrossRefGoogle Scholar
  2. Alexander, W. (2000). Fatal daughter syndrome. In R. Tong et al. Globalizing feminist bioethics (pp. 179–197). Boulder, CO: Westview Press.Google Scholar
  3. Andrews, L. (1999). The clone age. New York: Henry Holt.Google Scholar
  4. Andrews, L. (2006). Patently wrong: The first privately owned law of nature. Gene Watch, 19(3), 16–17.Google Scholar
  5. Arditti, R., Klein, R., & Minden, S. (Eds.) (1984). Test-tube women: What future for motherhood? London: Pandora Press.Google Scholar
  6. Beyond cloning: protecting humanity from species-altering procedures (2001). Boston, MA: Boston University School of Public Health.Google Scholar
  7. Burrell, D. E. (1995). The Norplant solution: Norplant and the control of African American motherhood. U.C.L.A. Women’s Law Journal, 5, 401.Google Scholar
  8. Callahan, J., & Knight, J. (1992). Women, fetuses, medicine and the law. In H. Holmes & L. Purdy (Eds.), Feminist perspectives in medical ethics (pp. 224–239). Bloomington, IN: Indiana University Press.Google Scholar
  9. Cicero, K. (2005). The 10 best fertility centers. Child magazine, 65–75. Retrieved October 20, 2007, from http://infertility-ivf.com/ChildMagazine.pdf
  10. Cohen, S., & Taub, S. (Eds.) (1989). Reproductive laws for the 1990s. Clifton, NJ: Humana Press.Google Scholar
  11. Cook, J. (1991). New reproductive technologies: International legal issues and instruments. Ottawa, ON: Royal Commission on New Reproductive Technologies.Google Scholar
  12. Corea, G. (1991). How the new reproductive technologies will affect all women. In H. P. Hynes (Ed.), Reconstructing babylon: Essays on women and technology (pp. 41–60). Bloomington, IN: Indiana University Press.Google Scholar
  13. CornerHouse (2000, July). The malthus factor: Poverty, politics and population in capitalist development: briefing Paper #20. Dorset: The CornerHouse.Google Scholar
  14. Correa, S. (1994). Population and reproductive rights: Feminist perspectives from the south. London: ZED Press.Google Scholar
  15. Darling, M. J. T. (1999). The state: friend or foe?: Distributive justice issues and African-American women. In J. Silliman & Y. King (Eds.), Dangerous intersections: Feminist perspectives on population, environment, and development (pp. 214–241). Boston, MA: South End Press.Google Scholar
  16. Darling, M. J. T. (2001). Gendered globalization, state interests: Women of color and marginalized women. N. Paradoxa International Feminist Art Journal, Economies/Exchanges, 8, 65–73.Google Scholar
  17. Darling, M. J. T. (2003). Eugenics unbound: Race, gender and genetics. In V. Agnew (Ed.), Women’s health, women’s rights: Perspectives on global health issues. Toronto, ON: York University.Google Scholar
  18. Darling, M. J. T. (2006). Gender, new technologies and development. Development, 49, 23–28.CrossRefGoogle Scholar
  19. Darnovsky, M. (2004). Hi-tech sex selection: A new chapter in the debate. Genewatch, 17(1).Google Scholar
  20. Degener, T. (1990). Female self-determination between feminist claims and “voluntary” eugenetics, between “rights” and ethics. Issues in Reproductive and Genetic Engineering, 87, 3.Google Scholar
  21. Dickenson, D. (2001). Property and women’s alienation from their own reproductive labour. Bioethics, 15, 205–217.PubMedCrossRefGoogle Scholar
  22. Dickenson, D. (2002a). Commentary–Commodification of human tissue: Implications for feminist and development ethics. Developing World Bioethics, 2, 55–63.PubMedCrossRefGoogle Scholar
  23. Dickenson, D. (2002b). Who owns embryonic and fetal tissue. In D. Dickenson (Ed.), Ethical issues in maternal-fetal medicine (pp. 233–246). Cambridge: Cambridge University Press.Google Scholar
  24. Feinman, C. (Ed.) (1992). The criminalization of a woman’s body. New York: Haworth Press.Google Scholar
  25. Forte, D. J., & Judd, K. (1998). The south within the north. In R. P. Petchesky & K. Judd (Eds.), Negotiating reproductive rights: Women’s perspectives across countries and cultures (pp. 256–294). London: ZED Press.Google Scholar
  26. Fowler, C. (1995). Biotechnology, patents and the third world. In V. Shiva & I. Moser (Eds.), Biopolitics: A feminist and ecological reader on biotechnology (pp. 214–225). London: ZED Books.Google Scholar
  27. Galpern, E., & Darnovsky, M. (2005). Eggs vs. ethics in stem cell debate. Nation. Retrieved November 29, 3005 from http://www.geneticsandsociety.org/article.php?id=199.
  28. Gender and justice in the gene age: a report from a feminist meeting on new reproductive and genetic technologies (2005). Retrieved November 20, 2007 from http://www.gjga.org.
  29. Gould, S.J. (1981). The mismeasure of man. New York: W.W. Norton.Google Scholar
  30. Grubb, A. (1998). I, me, mine: Body parts and property. Medical Law International, 3, 299–313.PubMedGoogle Scholar
  31. Haller, M. (1963). Eugenics: Hereditarian attitudes in american thought. New Brunswick, NJ: Rutgers University Press.Google Scholar
  32. Hartmann, B. (1995). Reproductive rights and wrongs: The global politics of population control (Rev. ed.). Boston, MA: South End Press.Google Scholar
  33. Hempel, C. (2006, June 25). Golden Eggs. Boston Globe Sunday Magazine.Google Scholar
  34. Hughes, J. (1996). Embracing change with all four arms. Eubios Journal of Asian and International Bioethic, 6, 94–101.Google Scholar
  35. Hynes, P. H. (1991). Biotechnology in agriculture and reproduction: The parallels in public policy. In P. H. Hynes (Ed.), Reconstructing babylon: Essays on women and technology (pp. 103–130). Bloomington, IN: Indiana University Press.Google Scholar
  36. Kevles, D. J. (1985). In the name of eugenics: Genetics and the uses of human heredity. Cambridge, MA: Harvard University Press.Google Scholar
  37. Klein, R., & Rowland, R. (1988). Women as test sites for fertility drugs. Reproductive and Genetic Engineering: International Feminist Analysis, 1, 251–73.Google Scholar
  38. Knoppers, B. M. (1999). Status, sale and patenting of human genetic material: An international survey. Nature Genetics, 22, 23–26.PubMedCrossRefGoogle Scholar
  39. Knowles, L. P., & Parens, E. (2003). Reprogenetics and public policy: Reflections and recommendations. The Hastings Report, 33.Google Scholar
  40. Kollek, R. (1995). The limits of experimental knowledge: A feminist perspective on the ecological risks of genetic engineering. In V. Shiva & I. Moser (Eds.), Biopolitics: A feminist and ecological reader on biotechnology (pp. 95–111). London: ZED Books.Google Scholar
  41. Lorber, J. (1992). Choice, gift, or patriarchal bargain?: Women’s consent in in vitro fertilization in male infertility. In H. Holmes & L. Purdy (Eds.), Feminist perspectives in medical ethics (pp. 169–180). Bloomington, IN: Indiana University Press.Google Scholar
  42. Lynn, R. (1994, January). Interview in Newsday.Google Scholar
  43. Mahowald, M. (2000). Cultural differences and sex selection. In Tong, R. et al. (Eds), Globalizing feminist bioethics (pp. 165–178). Boulder, CO: Westview Press.Google Scholar
  44. Maranto, G. (2003) Quest for perfection: The drive to breed better human beings (p. 278). New York: Scribner Books.Google Scholar
  45. Meleo-Erwin, Z. C. (2001). Reproductive technology: Welcome to the brave new world. In B. Tokar (Ed.), Redesigning life?: The worldwide challenge to genetic engineering (pp. 195–204). London/New York: ZED Books.Google Scholar
  46. Mies, M., & Shiva, V. (1993). Ecofeminism. London: ZED Books.Google Scholar
  47. Mooney, P. (2002). Making well people better. World Watch, 13–16.Google Scholar
  48. Nelson, J. (2003). Women of color and the reproductive rights movement. New York: New York University Press.Google Scholar
  49. Norsigian, J. (2005). Stem cell research and embryo cloning: Involving laypersons in the public debate. Symposium issue on stem cell research and human cloning: Where do we draw the line? New England Law Review, 39, 527–534.Google Scholar
  50. Ordover, N. (2003). American eugenics: Race, queer anatomy, and the science of nationalism. Minneapolis, MN: University of Minnesota Press.Google Scholar
  51. Papadimos, T., & Papadimos, A. (2004). The student and the ovum: The lack of autonomy and informed consent in trading genes for tuition. Reproductive Biology and Endocrinology, 2, 56. Retrieved November 20, 2007 from http://www.rbej.com/content/2/1/56
  52. Pence, G. (1998). Who’s afraid of human cloning? (p. 168). Lanham, MD: Rowman & Littlefield.Google Scholar
  53. Quadagno, J. (1996). The color of welfare: How racism undermined the war on poverty. New York: Oxford University Press.Google Scholar
  54. Radin, M. J. (1996). Contested commodities: The trouble with trade in sex, children, body parts and other things. Cambridge, MA: Harvard University Press.Google Scholar
  55. Raymond, J. G. (1991). Of eggs, embryos, and altruism. In P. H. Hynes (Ed.), Reconstructing babylon: Essays on women and technology (pp. 61–69). Bloomington, IN: Indiana University Press.Google Scholar
  56. Raymond, J. G. (1993). Women as wombs: Reproductive technologies and the battle over women’s freedom. Melbourne: Spinifex.Google Scholar
  57. ReproKult (2002). Reproductive medicine and genetic engineering: women between self-determination and societal standardization. Berlin: ReproKult, Women’s Forum for Reproductive Medicine Conference.Google Scholar
  58. The Return of Eugenics (2007). Genewatch, 20(1).Google Scholar
  59. Rich, A. (1977). The theft of childbirth. In C. Dreyfus (Ed.), Seizing our bodies: The politics of women’s health (pp. 146–163). New York: Vintage Press.Google Scholar
  60. Roberts, D. (1997). Killing the black body: Race, reproduction, and the meaning of liberty. New York: Pantheon Books.Google Scholar
  61. Roberts, D. (1999). Welfare’s ban on poor motherhood. In G. Mink (Ed.), Whose welfare? Ithaca, NY: Cornell University Press.Google Scholar
  62. Rodriquez-Trias, H. (1980). Sterilization abuse. In R. Arditti, P. Brennan, & S. Clark (Eds.), Science and liberation (pp. 113–127). Boston, MA: South End Press.Google Scholar
  63. Ross, L. J. et al. (2002). Just choices: Women of color, reproductive health and human rights. In J. Silliman & A. Bhattacharjee (Eds.), Policing the national body: Race, gender and criminalization (pp. 147–174). Boston, MA: South End Press.Google Scholar
  64. Sachs, S. (2001, August 15th). Clinics’ pitch to indian émigrés: It’s a boy. The New York Times.Google Scholar
  65. Sample, I. (2005, November). Genetic flaws in IVF embryos. The Guardian.Google Scholar
  66. Sherwin, S. (2000). Normalizing reproductive technologies and the implications for autonomy. In R. Tong, G. Anderson, & A. Santos (Eds.), Globalizing feminist bioethics: cross cultural perspectives (pp. 96–113). Boulder, CO: Westview Press.Google Scholar
  67. Silliman, J. Fried, M. G., Ross, L., & Gutierrez, E. R. (2004). Undivided rights: Women of color organize for reproductive justice. Boston, MA: South End Press.Google Scholar
  68. Silver, L. (2000). Reprogenetics: How do a scientist’s own ethical deliberations enter into the process? Humans and genetic engineering in the new millennium: How are we going to get “gen-ethics” just in time?. Copenhagen: Danish Council of Ethics.Google Scholar
  69. Sparr, P. (Ed.) (1994). Mortgaging women’s lives: Feminist critiques of structural adjustment. London: ZED Books.Google Scholar
  70. Stock, G. (2002). Redesigning humans: our inevitable genetic future (p. 55). New York: Houghton Mifflin.Google Scholar
  71. Tauer, C. (2004). International policy failures: Cloning and stem-cell research. The Lancet, 364, 9429.CrossRefGoogle Scholar
  72. Tokar, B. (Ed.) (2001). Redesigning life: The worldwide challenge to genetic engineering. London: ZED Books.Google Scholar
  73. Washenfelder, C. (2002). Regulating a revolution: the extent of reproductive rights in Canada. Health Law Review, 12(2), 44–52.Google Scholar
  74. Wertz, D.C., & Fletcher, J. (1992). Sex selection through prenatal diagnosis: A feminist critique. In H. B. Holmes & L. Purdy (Eds.), Feminist perspectives in medical ethics (pp. 240–256). Bloomington, IN: Indiana University Press.Google Scholar

Copyright information

© Springer Science + Business Media B.V 2008

Authors and Affiliations

  1. 1.Adelphi UniversityGarden CityUSA

Personalised recommendations